The most common cause of hair loss in both men and women. DHT — a hormone derived from testosterone — gradually miniaturises genetically susceptible follicles until they stop producing hair entirely.
Androgenetic alopecia — commonly called male pattern baldness in men and female pattern hair loss in women — is a genetic condition in which hair follicles in specific scalp zones are programmed to be sensitive to DHT.
It is not caused by wearing hats, poor circulation, or washing hair too often. The cause is genetic DHT sensitivity — inherited from either parent, not just the maternal line as is commonly believed.
In men, loss follows the Norwood scale — typically beginning at the temples and crown. In women, loss follows the Ludwig scale — diffuse thinning across the crown with hairline preservation.
The back and sides of the scalp contain follicles that are genetically resistant to DHT. When transplanted, these follicles retain their DHT-resistant characteristics in the new location — which is why well-performed FUE results are permanent.
Medical treatment works best when started early — before significant follicle miniaturisation has occurred. Dr Qurbain's FFPM qualification means he brings deep pharmacological expertise to medication discussions that most hair clinics cannot offer.
Inhibits 5-alpha reductase type II, reducing scalp DHT by approximately 70%. Proven to slow progression and stimulate regrowth in most men. Requires ongoing use — stopping reverses benefit within 12 months.
Not suitable for women of childbearing age. Post-menopausal women may be considered.
Inhibits both type I and type II 5-alpha reductase, reducing scalp DHT by over 90%. More potent than finasteride. Used off-label for hair loss — discussed at consultation for suitable candidates.
Greater DHT suppression, similar side effect profile to finasteride.
Extends the anagen (growth) phase and increases follicle size. Works independently of DHT — effective in both men and women. Available as 5% topical or low-dose oral (0.25–1.25mg daily).
Oral minoxidil increasingly preferred for compliance and systemic effect.
Concentrated platelets from your own blood injected into the scalp release growth factors that stimulate miniaturised follicles. Best used alongside medical treatment, not as a standalone.
Typically 3 sessions initially, then 6–12 monthly maintenance.
FUE hair transplant restores areas of permanent follicle loss using DHT-resistant donor follicles from the back and sides of the scalp. It does not stop ongoing DHT-driven loss in untreated areas — which is why medical treatment and surgical planning must be considered together.
Send DrQ a photo and he will personally assess your pattern, advise on whether medical treatment or surgical assessment is appropriate, and answer your questions directly.
No consultation fee. No commitment. Personal reply within 24 hours.